Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma. [electronic resource]
- Cancer science Oct 2013
- 1303-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1349-7006
10.1111/cas.12223 doi
ATP Binding Cassette Transporter, Subfamily B--biosynthesis Alligators and Crocodiles Animals Antineoplastic Agents--pharmacology Bile--chemistry Bile Duct Neoplasms--genetics Bile Ducts, Intrahepatic--metabolism Cell Cycle Cell Line, Tumor--drug effects Cell Size Cholangiocarcinoma--genetics Down-Regulation--drug effects Drug Resistance, Multiple--drug effects Drug Resistance, Neoplasm--drug effects Gene Expression Regulation, Neoplastic--drug effects Humans Neoplasm Proteins--antagonists & inhibitors RNA Interference RNA, Small Interfering--pharmacology Real-Time Polymerase Chain Reaction Tissue Extracts--pharmacology Wnt Signaling Pathway--drug effects Wnt3A Protein--pharmacology beta Catenin--antagonists & inhibitors ATP-Binding Cassette Sub-Family B Member 4